US HEVA Dupixent Team Lead

Responsibilities Lead US HEVA strategy and execution for Dupixent across indications, ensuring generation, translation, and dissemination of high‑quality decision‑relevant evidence to impact US access. Drive measurable US HEVA business impact aligned to US commercial objectives and market access goals. Develop and execute US HEVA strategies aligned with Global HEVA strategy; partner with commercial teams to translate HEVA insights into business strategy. Provide exceptional leadership, mentor team members, drive change/process improvements, and represent HEVA with US Dupixent Franchise Leadership Team. Build cross‑functional partnerships to support pricing/access decisions with robust evidence (including real‑world evidence); align with Global HEVA to coordinate evidence generation, modelling, and synthesis. Present complex health economics concepts to senior leadership; influence key decisions via data‑driven HEVA recommendations; ensure clinical development plans enable differentiation. Oversee design, execution, publication, and dissemination of health economics and outcomes research; develop real‑world evidence strategies. Ensure scientific rigor and regulatory compliance; manage US launch/evidence generation plans and provide HEVA input to Integrated Evidence Generation Plans (IEGPs). Lead compliant HEOR dissemination and proactive/promotional use with US stakeholders (e.g., HCEI/PIE, consistent with FDA label). Partner with Access Strategy and US Market Access to execute payer partnership studies and analytics. Engage external stakeholders (payers, HTA bodies, academics); represent Sanofi at major conferences; collaborate with KOLs/partners; engage evidence bodies (e.g., ICER, PDAB, IRA). Qualifications Minimum 10 years in health economics, outcomes research, or related field. Advanced degree (PhD, PharmD, Masters or equivalent) in health economics, epidemiology, public health, economics, or related field (required). Expertise in health economic modeling, real‑world evidence generation, and outcomes research. Deep knowledge of US healthcare, payer dynamics, and policy; track record translating evidence into strategic impact. Proven experience supporting market access/reimbursement and influencing decision‑making using HEVA insights. Strong US evidence dissemination experience (HCEI/PIE, reactive/proactive, CFL, AMCP dossiers). Exceptional leadership, change management, and cross‑functional collaboration skills. Extensive immunology experience (disease pathophysiology, treatment paradigms, market dynamics). Strong written/verbal English communication; ability to synthesize complex data into actionable recommendations. 20% domestic/international travel. Benefits Health and wellbeing benefits including high‑quality healthcare, prevention and wellness programs, and at least 14 weeks’ gender‑neutral parental leave. #J-18808-Ljbffr Scorpion Therapeutics